Starpharma Stock: Patience Needed, But A Lot To Like (OTCMKTS:SPHRF)


dendrimer for drug delivery 3d rendering

Love Employee/iStock via Getty Images

Investing in early stage Biotech companies is fraught with risk, but the upside can be worthwhile if one has the patience to leave an early investment in the bottom drawer. Australian biotech company Starpharma (



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *